Ilyang Pharmaceutical Co Ltd (007575) — Net Asset Quality Index
Ilyang Pharmaceutical Co Ltd (007575) has a Net Asset Quality Index of 53.8% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩444.81 Billion minus total liabilities of ₩205.41 Billion yields net assets of ₩239.41 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read total liabilities of Ilyang Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Ilyang Pharmaceutical Co Ltd Net Asset Quality Index Over Time (2014–2024)
This chart shows how Ilyang Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 11 annual periods from 2014 to 2024. As of June 2025, the index stands at 53.8%, representing net assets of ₩239.41 Billion against total assets of ₩444.81 Billion KRW. For live market cap and overall valuation, see Ilyang Pharmaceutical Co Ltd market cap and net worth.
Annual Net Asset Quality Index for Ilyang Pharmaceutical Co Ltd (2014–2024)
The table below presents the year-by-year Net Asset Quality Index for Ilyang Pharmaceutical Co Ltd from 2014 to 2024, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Ilyang Pharmaceutical Co Ltd (007575) strategic investment index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 56.0% | ₩241.58 Billion | ₩431.21 Billion | ₩189.63 Billion | ▲ +1.0 pp |
| 2023 | 55.1% | ₩196.41 Billion | ₩356.66 Billion | ₩160.25 Billion | ▼ -3.5 pp |
| 2022 | 58.6% | ₩291.85 Billion | ₩498.19 Billion | ₩206.33 Billion | ▲ +3.6 pp |
| 2021 | 55.0% | ₩271.76 Billion | ₩494.27 Billion | ₩222.51 Billion | ▼ -0.8 pp |
| 2020 | 55.8% | ₩244.92 Billion | ₩439.12 Billion | ₩194.19 Billion | ▲ +4.9 pp |
| 2019 | 50.9% | ₩222.74 Billion | ₩437.46 Billion | ₩214.72 Billion | ▲ +2.4 pp |
| 2018 | 48.6% | ₩209.88 Billion | ₩432.25 Billion | ₩222.37 Billion | ▲ +0.2 pp |
| 2017 | 48.3% | ₩210.98 Billion | ₩436.37 Billion | ₩225.39 Billion | ▼ -2.1 pp |
| 2016 | 50.4% | ₩217.35 Billion | ₩431.26 Billion | ₩213.91 Billion | ▲ +1.5 pp |
| 2015 | 48.9% | ₩211.00 Billion | ₩431.63 Billion | ₩220.62 Billion | ▲ +6.3 pp |
| 2014 | 42.6% | ₩183.46 Billion | ₩430.83 Billion | ₩247.37 Billion | — |